OVID SCHEDULE 13G/A: SEC filing

ADAR1 Capital Management, LLC and Daniel Schneeberger

Filed with the SEC on · accession 0001104659-26-128698

OVID filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. ADAR1 Capital Management, LLC and Daniel Schneeberger filed an amended Schedule 13G reporting beneficial ownership of 6,703,313 shares (3.5%) of Ovid Therapeutics Inc. common stock as of September 30, 2026, held passively through ADAR1 Partners, LP, Spearhead Insurance Solutions IDF, LLC, and… The stock moved -5.5% by the first close after the filing.

Summary of the filing

ADAR1 Capital Management, LLC and Daniel Schneeberger filed an amended Schedule 13G reporting beneficial ownership of 6,703,313 shares (3.5%) of Ovid Therapeutics Inc. common stock as of September 30, 2026, held passively through ADAR1 Partners, LP, Spearhead Insurance Solutions IDF, LLC, and separately managed accounts.

Key details

Shares beneficially owned$6.7M
Percent of class owned$4
Shares outstanding of issuer$188.7M
Reporting person / investment managerADAR1 Capital Management, LLC
IssuerOvid Therapeutics Inc.
Holder of 4,123,422 shares and 2,142,500 warrantsADAR1 Partners, LP
Holder of 435,032 sharesSpearhead Insurance Solutions IDF, LLC
Manager of adar1 capital management, llcDaniel Schneeberger

How OVID stock reacted

Close before

$2.54

Nov 13, 2026

First close after

-5.51%

$2.40

5 trading days

—

Since filing

-12.60%

$2.22

✦ Ask GOAX AI about this filing — what it means for OVID, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for OVID?

Click here

Frequently asked questions

What did OVID file with the SEC on Nov 16, 2026?

OVID filed a SCHEDULE 13G/A (SEC filing). ADAR1 Capital Management, LLC and Daniel Schneeberger filed an amended Schedule 13G reporting beneficial ownership of 6,703,313 shares (3.5%) of Ovid Therapeutics Inc. common stock as of September 30, 2026, held passively through ADAR1 Partners, LP, Spearhead Insurance Solutions IDF, LLC, and separately managed accounts.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did OVID stock react to this filing?

OVID closed at $2.54 before the filing and $2.40 on Nov 16, 2026 (-5.51%).

Other OVID SEC filings

Get alerts when OVID files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days